Home › Colorectal Cancer › Michigan › Dearborn
Colorectal Cancer clinical trials in Dearborn, MI
4 studies for Colorectal Cancer are looking for participants at sites in and around Dearborn (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Vanguard Study: Testing a New Way to Screen for Cancer
RecruitingHealthy volunteers welcome
- Henry Ford Medical Center-Fairlane, Dearborn
- Henry Ford Wyandotte Hospital, Wyandotte · 8 mi away
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
RecruitingPhase 2
- Corewell Health Dearborn Hospital, Dearborn
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Corewell Health Dearborn Hospital, Dearborn
- Henry Ford Medical Center-Fairlane, Dearborn
- Henry Ford Wyandotte Hospital, Wyandotte · 8 mi away
A Study of IBI363 in Subjects with Advanced Solid Malignancies
RecruitingPhase 2
- Michigan Hematology & Oncology Consultants - MedOnc Dearborn, Dearborn
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX102 studies
- New York City, NY78 studies
- Nashville, TN69 studies
- Boston, MA63 studies
- Los Angeles, CA59 studies
- Arlington, VA52 studies
- St. Louis, MO50 studies
- San Antonio, TX46 studies
- Philadelphia, PA44 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA37 studies
- Chicago, IL34 studies
Other studies in Dearborn
- Non-Small Cell Lung Cancer6 studies
- Breast Cancer6 studies
- Lung Cancer6 studies
- Prostate Cancer6 studies
- Bladder Cancer4 studies
- COPD4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Ovarian Cancer3 studies
- Pancreatic Cancer3 studies
- Type 2 Diabetes3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.